NCT07047378 ACT-Based Training for Parental Burnout and Child Well-being
| NCT ID | NCT07047378 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Child Abuse |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-04-22 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-04-22 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the proposed randomized controlled trial is to evaluate the feasibility, acceptability, and potential effectiveness of Acceptance and Commitment Therapy (ACT) in reducing parental burnout and improving children's emotional and behavioral adjustment in families in Hong Kong over 3 months after the intervention. The findings will provide valuable and scientific insights to inform better parenting interventions and child protection policies.
Eligibility Criteria
Inclusion Criteria: For the Parent ACT Group: 1. Cantonese-speaking Hong Kong residents between the ages of 19 and 65 years. 2. Primary caregivers of a child aged 3 to 11 years. 3. Have been identified by school social workers as being at risk of domestic violence or experiencing emotional distress. For the Child ACT Group: 1. Cantonese-speaking Hong Kong residents between the ages of 3 and 11 years. 2. Have been identified by school social workers as being at risk of domestic violence or experiencing emotional distress. For both groups (Shared inclusion criteria): 1. Participants must have sufficient Cantonese language proficiency to understand and communicate during the intervention. 2. Both parents and children must provide informed consent to participate in the study and all related assessments. Exclusion Criteria: For the Parent ACT Group: 1. Parents diagnosed with severe mental illnesses. 2. Parents with a developmental disability that interferes with their ability to comprehend the program's content. 3. Parents with cognitive, language, communication, visual, or hearing impairments or disorders that could impede their understanding of the intervention content; or 4. Parents currently participate in other psychosocial, psychoeducational, or parenting interventions. 5. Parents with active substance abuse issues that may interfere with their ability to participate in or benefit from the program. 6. Parents whose children have been diagnosed with psychological or medical conditions. For the Child ACT Group: 1\. Children who have been diagnosed with psychological or medical conditions. For both groups (Shared Exclusion criteria): 1. Families who are unable or unwilling to commit to attending the six-week sessions or completing follow-up assessments. 2. Families who lack access to transportation or other necessary resources to attend the intervention sessions 3. Parents and children who cannot understand or communicate in the language used in the intervention and assessments (i.e., Cantonese and Chinese).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07047378 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 65 Years, studying Child Abuse. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07047378 currently recruiting?
Yes, NCT07047378 is actively recruiting participants. Contact the research team at conniechong@cuhk.edu.hk for enrollment information.
Where is the NCT07047378 trial being conducted?
This trial is being conducted at Kwun Tong, Hong Kong, Shatin, Hong Kong.
Who is sponsoring the NCT07047378 clinical trial?
NCT07047378 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 120 participants.